VINCOV-19

VINCOV-19 is a drug developed by the CSIR-Centre for Cellular and Molecular Biology. This might the first specific drug for COVID-19 treatment. It is made of antibodies collected from horses that were vaccinated against COVID-19 infection. It had recently received the Drug Controller General of India’s approval for phase I and phase II trials. It is expected to be launched for trials in Delhi and Rajasthan.

Comments

Leave a Reply